205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.92%
Negative revenue growth while INTC stands at 6.16%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-2.87%
Negative gross profit growth while INTC is at 20.40%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1.68%
Negative EBIT growth while INTC is at 42.12%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.68%
Negative operating income growth while INTC is at 42.12%. Joel Greenblatt would press for urgent turnaround measures.
-2.71%
Negative net income growth while INTC stands at 26.80%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.18%
Share reduction while INTC is at 0.05%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-3.45%
Reduced diluted shares while INTC is at 0.35%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
25.02%
Dividend growth above 1.5x INTC's 0.25%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-7.05%
Negative OCF growth while INTC is at 22.86%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-9.93%
Negative FCF growth while INTC is at 25.14%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
66.42%
10Y revenue/share CAGR at 50-75% of INTC's 101.16%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
96.86%
5Y revenue/share CAGR 1.25-1.5x INTC's 69.00%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
41.72%
3Y revenue/share CAGR above 1.5x INTC's 20.30%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
241.13%
10Y OCF/share CAGR above 1.5x INTC's 67.80%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
127.23%
5Y OCF/share CAGR above 1.5x INTC's 53.10%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
37.02%
3Y OCF/share CAGR 1.25-1.5x INTC's 25.00%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
401.02%
Net income/share CAGR above 1.5x INTC's 59.21% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
252.29%
5Y net income/share CAGR above 1.5x INTC's 144.55%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
93.61%
3Y net income/share CAGR above 1.5x INTC's 15.31%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
91.65%
10Y equity/share CAGR at 50-75% of INTC's 170.80%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
10.40%
Below 50% of INTC's 36.19%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-4.05%
Negative 3Y equity/share growth while INTC is at 19.48%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
361.20%
Below 50% of INTC's 1543.35%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
355.42%
5Y dividend/share CAGR at 75-90% of INTC's 463.96%. Bill Ackman wants more robust earnings or a higher payout ratio to match the competitor.
294.10%
3Y dividend/share CAGR above 1.5x INTC's 181.88%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-13.89%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.21%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-7.70%
Negative asset growth while INTC invests at 4.92%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-7.50%
We have a declining book value while INTC shows 4.49%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-6.09%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-1.63%
We cut SG&A while INTC invests at 6.10%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.